Nvidia CEO Jensen Huang Said AI's "Most Profound Impact Will Be in Life Sciences." Does This Bet on a Biotech Stock Prove He Means It?
Yahoo Finance ·
Nvidia ( NVDA +3.90% ) is known as one of the most advanced makers of chips powering the breakthroughs in artificial intelligence (AI). But what some people may not know is that Nvidia is also an investor in other companies. Among its investments, it holds stakes in cloud computing provider CoreWeave , chip designer and manufacturer Intel , and telecommunications company Nokia . But at the bottom of one of its May financial filings, it also listed an investment in a small biotech company: Generate Biomedicines ( GENB 8.87% ) . That may not seem to fit the pattern of investing in tech operators. But Nvidia CEO Jensen Huang sees an important intersection between the healthcare field and AI. At a January conference, Nvidia announced it was forming an AI co-innovation lab with Eli Lilly . Over five years, both companies plan to jointly invest up to $1 billion in the lab's infrastructure and research.
DYAX Investor Sentiment
Bullish (Long) 45% · Bearish (Short) 55%
538 participants
Related News
- Elon Musk roasts OpenAI's Apple lawsuit — but Altman hits back: 'You're the one selling investors on space datacenters'
- Can Nvidia Still Turn Long-Term Investors Into Millionaires?
- 'LOL ... so funny': Apple says ex-engineer stole secrets and coached a colleague to do the same. He now works at OpenAI
- Overwhelmed by Investing? Here's the Quickest Way to Simplify the Process.
- 2 Top Power Stocks That Could Outperform the Market Through 2030
- Top global stories last week: Vodafone, easyJet among major names